Page 2 - Les Meilleurs doctors pour le traitement de léiomyosarkome en Turquie - TOP-26 des médecins

Le professeur Dr Mehmet Karaca est spécialisé dans les cancers gynécologiques, y compris le léiomyosarcome, avec une formation approfondie en chirurgie oncologique gynécologique.

• Plus de 20 ans d'expérience en gynécologie et obstétrique
• Spécialisé en chirurgie oncologique gynécologique au ministère de la Santé
• Membre actuel du corps professoral du complexe hospitalier Medical Park Antalya
• Expert en chirurgie laparoscopique pour les cancers gynécologiques

Le Dr Topcu a été formé dans les plus grands centres de cancérologie au monde, notamment MD Anderson et Moffitt aux États-Unis, apportant une expertise mondiale aux cas de léiomyosarcome.

• Plus de 17 ans d'expérience en oncologie médicale avec une formation spécialisée
• Membre de l'ESMO et de l'ASCO – les principales sociétés d'oncologie
• Prendre en charge spécifiquement les cancers des tissus mous rares/sarcomes
• Travailler au département d'oncologie de l'hôpital universitaire Biruni

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.